查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411304

臨床試驗用品市場：2024-2030 年按階段、類型、產品、治療領域和最終用戶分類的全球預測

Clinical Trial Supplies Market by Phase (Phase 1, Phase 2, Phase 3), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年臨床試驗用品市場規模為33.5億美元，預計2024年將達36.4億美元，2030年將達到59.2億美元，複合年成長率為8.43%。

全球臨床試驗用品市場

主要市場統計
基準年[2023] 33.5億美元
預測年份 [2024] 36.4億美元
預測年份 [2030] 59.2億美元
複合年成長率（%） 8.43%
臨床試驗用品市場-IMG1

臨床試驗用品是臨床研究的基本且複雜的組成部分，最終有助於為成功的治療方法突破和患者治療途徑的突破性改進鋪平道路。這些藥物支持從臨床前測試到上市後監測的各個研究階段，促進臨床試驗的無縫管理和進行。全球感染疾病和慢性病的流行以及隨之而來的製藥和生物製藥行業的臨床試驗和研發費用的增加將刺激市場成長。與臨床試驗供應相關的高成本、嚴格的供應法規以及跨境物流挑戰限制了市場成長。專注於藥物開發和轉向以患者為中心的臨床試驗可以改善臨床試驗患者招募、試驗入組和參與者保留率。各種臨床試驗用品的進步預計也將為製藥和生物製藥公司開闢新的研究途徑。

區域洞察

以美國和加拿大為中心的美洲地區慢性病診斷率高，醫療基礎設施強大，對臨床試驗供應高度依賴。去年註冊的主要專利與最佳化供應鏈模型和採用先進分析來匹配測試供應與需求有關。由於醫療保健的取得和支出存在差異，歐盟 (EU)、中東和非洲的需求多種多樣。在歐洲，受研發重點投資和老年人口快速成長的推動，對臨床試驗用品的需求穩定。相較之下，中東和非洲國家是新興市場，研究活動活躍但由於資金和基礎設施有限而進展緩慢。包括中國、日本和印度在內的亞太地區由於醫療基礎設施的大量投資，疾病發生率很高。蓬勃發展的製藥業正在推動這些地區的臨床試驗用品市場，其需求是由成本效益而不是速度驅動的。

FPNV定位矩陣

FPNV定位矩陣對於評估臨床試驗用品市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對臨床試驗用品市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-臨床試驗用品市場的市場規模與預測是多少？

2-在臨床試驗用品市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-臨床試驗用品市場的技術趨勢和法律規範是什麼？

4-臨床試驗用品市場主要供應商的市場佔有率為何？

5-進入臨床試驗用品市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 製藥和生物製藥產業研發支出增加
    • 抑制因素
      • 臨床試驗耗材成本高
    • 機會
      • 重視藥物開發並轉向以病人為中心的臨床試驗
      • 多樣化臨床試驗用品的持續進步
    • 任務
      • 臨床試驗用品嚴格監管
  • 市場區隔分析
    • 階段：對臨床試驗用品的需求隨著每個階段的增加而增加，以便做出有關臨床試驗的最佳決策
    • 類型：慢性病治療方法突破導致生物製藥需求激增
    • 產品：輔助藥物是臨床試驗的重要組成部分，因為它們對於確保研究的安全性和整體效率具有重要意義。
    • 治療領域：世界各地日益增加的感染疾病負擔正在創造對臨床試驗用品的需求
    • 最終用戶：由於研發活動外包的增加，CRO 中臨床試驗用品的使用增加
  • 市場趨勢分析
    • 老牌製藥公司專注於增加臨床試驗數量，以及美洲對臨床試驗用品不斷成長的需求
    • 擴大政府支持法規和標準的力度，並加強亞太地區的臨床試驗能力
    • 歐洲、中東和非洲地區臨床試驗數量不斷增加，製藥業強大且先進
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 臨床試驗用品市場分階段狀況

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第7章 臨床試驗用品市場：依類型

  • 生物製藥
  • 醫療設備
  • 低分子

第8章臨床試驗用品市場：依產品

  • 補充藥物
  • 互動式回應技術 (IRT) 解決方案
  • 實驗室用品
    • 離心機
    • 顯微鏡
    • 吸管
    • 試劑
  • 醫療設備和診斷
  • 藥局用品
    • 生物危害袋
    • 複合式無菌隔離器
    • 消毒器
  • 調查數據
  • 安全裝置

第9章依治療領域分類的臨床試驗用品市場

  • 心臟病學
  • 遺傳疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 神經病學
  • 腫瘤學

第10章臨床試驗用品市場：依最終使用者分類

  • 合約研究組織
  • 製藥和生物技術公司

第11章 北美和南美臨床試驗用品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗用品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東、非洲臨床試驗用品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第15章競爭組合

  • 主要公司簡介
    • 3M Company
    • Abbott Laboratories
    • Almac Group Limited
    • B. Braun SE
    • Baxter International, Inc.
    • Bayer AG
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Cardinal Health, Inc.
    • Charles River Laboratories, Inc.
    • COREX LOGISTICS LIMITED
    • Emsere BV by Medicapital Holdco BV
    • Eppendorf SE
    • Evident Corporation by Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Fujifilm Group
    • Hipro Biotechnology Co., Ltd.
    • Hitachi, Ltd.
    • HORIBA, Ltd.
    • ICON PLC
    • Immudex ApS
    • Incyte Corporation
    • IQVIA Inc.
    • Johnson & Johnson Services, Inc.
    • KLIFO A/S
    • Labnet International
    • Leica Microsystems GmbH by Danaher Corporation
    • llumina, Inc.
    • Lonza Group Ltd.
    • Medline Industries, LP
    • Merck KGaA
    • Myonex, LLC
    • Novo Nordisk A/S
    • Nuvisan GmbH
    • Parexel International Corporation
    • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • PerkinElmer Inc. by Revvity, Inc.
    • Pfizer Inc.
    • Promega Corporation
    • Recipharm AB
    • Rubicon Research Pvt. Ltd.
    • Sekisui Diagnostics Group
    • Sharp Services, LLC
    • Siemens Healthcare GmbH
    • Smith & Nephew PLC
    • Stryker Corporation
    • Thermo Fisher Scientific Inc.
    • Woodley Equipment Company Ltd.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-E0619F076722

[187 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Global Clinical Trial Supplies Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%
Clinical Trial Supplies Market - IMG1

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supplies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Type Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supplies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supplies Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supplies Market?

4. What is the market share of the leading vendors in the Clinical Trial Supplies Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supplies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Clinical Trial Supplies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
    • 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
    • 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
    • 8.5.1. Centrifuges
    • 8.5.2. Microscopes
    • 8.5.3. Pipettes
    • 8.5.4. Reagents
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
    • 8.7.1. Biohazard Bags
    • 8.7.2. Compounding Aseptic Isolators
    • 8.7.3. Sterilization Equipment
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
      • 14.3.1.2. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
      • 14.3.1.3. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
      • 14.3.2.2. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
      • 14.3.2.3. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
      • 14.3.2.4. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Thermo Fisher Scientific Launches New Smart Refrigerator Series
      • 14.3.3.2. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.4. Investment & Funding
      • 14.3.4.1. Experic Closes USD 14 Million Series B Financing
      • 14.3.4.2. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
    • 14.3.5. Award, Recognition, & Expansion
      • 14.3.5.1. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. 3M Company
    • 15.1.2. Abbott Laboratories
    • 15.1.3. Almac Group Limited
    • 15.1.4. B. Braun SE
    • 15.1.5. Baxter International, Inc.
    • 15.1.6. Bayer AG
    • 15.1.7. Becton, Dickinson and Company
    • 15.1.8. Bio-Rad Laboratories, Inc.
    • 15.1.9. Bruker Corporation
    • 15.1.10. Cardinal Health, Inc.
    • 15.1.11. Charles River Laboratories, Inc.
    • 15.1.12. COREX LOGISTICS LIMITED
    • 15.1.13. Emsere B.V by Medicapital Holdco B.V.
    • 15.1.14. Eppendorf SE
    • 15.1.15. Evident Corporation by Olympus Corporation
    • 15.1.16. F. Hoffmann-La Roche Ltd.
    • 15.1.17. Fujifilm Group
    • 15.1.18. Hipro Biotechnology Co., Ltd.
    • 15.1.19. Hitachi, Ltd.
    • 15.1.20. HORIBA, Ltd.
    • 15.1.21. ICON PLC
    • 15.1.22. Immudex ApS
    • 15.1.23. Incyte Corporation
    • 15.1.24. IQVIA Inc.
    • 15.1.25. Johnson & Johnson Services, Inc.
    • 15.1.26. KLIFO A/S
    • 15.1.27. Labnet International
    • 15.1.28. Leica Microsystems GmbH by Danaher Corporation
    • 15.1.29. llumina, Inc.
    • 15.1.30. Lonza Group Ltd.
    • 15.1.31. Medline Industries, LP
    • 15.1.32. Merck KGaA
    • 15.1.33. Myonex, LLC
    • 15.1.34. Novo Nordisk A/S
    • 15.1.35. Nuvisan GmbH
    • 15.1.36. Parexel International Corporation
    • 15.1.37. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • 15.1.38. PerkinElmer Inc. by Revvity, Inc.
    • 15.1.39. Pfizer Inc.
    • 15.1.40. Promega Corporation
    • 15.1.41. Recipharm AB
    • 15.1.42. Rubicon Research Pvt. Ltd.
    • 15.1.43. Sekisui Diagnostics Group
    • 15.1.44. Sharp Services, LLC
    • 15.1.45. Siemens Healthcare GmbH
    • 15.1.46. Smith & Nephew PLC
    • 15.1.47. Stryker Corporation
    • 15.1.48. Thermo Fisher Scientific Inc.
    • 15.1.49. Woodley Equipment Company Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • FIGURE 4. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • FIGURE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2019-2023
  • TABLE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 17. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 19. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 21. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 22. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 23. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 24. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 25. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 26. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 27. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 28. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 29. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 30. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 31. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 32. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 33. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 34. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 35. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 36. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 37. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 38. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 39. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 40. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 41. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 65. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 71. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 72. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2019-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 101. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 102. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 108. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 109. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 115. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 116. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 122. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 123. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 130. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 144. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 157. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 158. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 164. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 165. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 171. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 172. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 186. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 187. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 193. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 194. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 200. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 201. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 207. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 208. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 214. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 215. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 221. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 222. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 228. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 229. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 242. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 243. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 249. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 250. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 256. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 257. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 263. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 264. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 270. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 271. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 291. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 292. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 298. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 299. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 312. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 313. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 333. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 334. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 335. CLINICAL TRIAL SUPPLIES MARKET LICENSE & PRICING